Role of radiotherapy in the management of node-positive prostate cancer

被引：2
|
作者：
Supiot, S. [1 ]
Dore, M. [1 ]
Rio, E. [1 ]
Cellier, P. [1 ]
Mesguez-Nebout, N. [1 ]
Goineau, A. [1 ]
机构：
[1] Inst Cancerol Ouest Rene Gauducheau, Dept Radiotherapie, Blvd Jacques Monod, F-44805 St Herblain, France
来源：
CANCER RADIOTHERAPIE | 2016年 / 20卷 / 6-7期
关键词：
Prostate adenocarcinoma; pN1; cN1; N1; Metastatic prostate cancer; Oligometastases; Irradiation; Pelvis; Androgen depriving therapy; Hormonetherapy; RADIATION-THERAPY; RADICAL PROSTATECTOMY; ADJUVANT; FAILURE;
D O I：
10.1016/j.canrad.2016.06.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Node-positive prostate cancer patients represent a small proportion of all prostate cancers for whom limited prospective information is available. Most retrospective or cohort data strongly suggest however that radiotherapy combined with androgen-depriving therapies is the preferable treatment in this setting. Only randomized clinical trials would be able to better define both radiotherapy (dose? volume? fractionation?) and androgen-depriving therapies (duration? role of novel androgen-depriving therapy?) modalities. (C) 2016 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：442 / 444
页数：3
相关论文
共 50 条
  • [1] The Role of Radiotherapy in Node-Positive Prostate Cancer
    Baker, Brock R.
    Mohiudin, Jahan J.
    Chen, Ronald C.
    ONCOLOGY-NEW YORK, 2015, 29 (02): : 108 - 116
  • [2] Radiotherapy in node-positive prostate cancer
    Bottke, D.
    Bartkowiak, D.
    Bolenz, C.
    Wiegel, T.
    UROLOGE, 2016, 55 (03): : 345 - 349
  • [3] The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer
    Jegadeesh, Naresh
    Liu, Yuan
    Zhang, Chao
    Zhong, Jim
    Cassidy, Richard J.
    Gillespie, Theresa
    Kucuk, Omer
    Rossi, Peter
    Master, Viraj A.
    Alemozaffar, Mehrdad
    Jani, Ashesh B.
    CANCER, 2017, 123 (03) : 512 - 520
  • [4] Moderately Hypofractionated Radiotherapy in Node-positive Prostate Cancer
    Mallick, I
    Das, A.
    Arunsingh, M.
    CLINICAL ONCOLOGY, 2019, 31 (04) : 260 - 264
  • [5] Management of Node-Positive and Oligometastatic Prostate Cancer
    Broughman, James R.
    Chen, Ronald C.
    SEMINARS IN RADIATION ONCOLOGY, 2017, 27 (01) : 79 - 86
  • [6] Whole pelvis radiotherapy for pathological node-positive prostate cancer
    Poelaert, Filip
    Fonteyne, Valerie
    Ost, Piet
    De Troyer, Bart
    Decaestecker, Karel
    De Meerleer, Gert
    De Visschere, Pieter
    Claeys, Tom
    Dhondt, Bert
    Lumen, Nicolaas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (06) : 444 - 451
  • [7] Radiotherapy for node-positive prostate cancer correlates with improved survival
    Elumalai, T.
    Portner, R.
    Mariam, N. B. G.
    Young, T.
    Hughes, S.
    Wickramasinghe, K.
    Bhana, R.
    Jayaprakash, K. T.
    Sabar, M.
    Hudson, A.
    Hoskin, P.
    Mistry, H.
    Choudhury, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S481 - S483
  • [8] Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer
    Amaya, Enrique
    Carrasco, Eliseo
    Lopez, Marta
    Gomez-Aparicio, Marta Antonia
    Pelari-Mici, Lira
    Duque-Santana, Victor
    Zafra, Juan
    Sargos, Paul
    Campos, Fernando Lopez
    Achard, Verane
    Counago, Felipe
    ARCHIVOS ESPANOLES DE UROLOGIA, 2023, 76 (10): : 718 - 732
  • [9] Management of Lymph Node-Positive Prostate Cancer: The Role of Surgery and Radiation Therapy
    Mitin, Timur
    Blute, Michael
    Lee, Richard
    Efstathiou, Jason
    ONCOLOGY-NEW YORK, 2013, 27 (07): : 647 - 655
  • [10] Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
    Angela Y. Jia
    Daniel E. Spratt
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 1 - 2
12345